Tristel slumps on dual effects of the pandemic

The group has seen both positive and negative effects of the pandemic

July 22, 2020

Trading at Tristel (TSTL), a manufacturer of infection prevention products, has been at the mercy of what the company described as “two powerful countervailing forces”.

IC TIP: Buy at 415p

This is subscriber only content

Start your trial to keep reading

PRINT AND DIGITAL trial

Get 12 weeks for £12

Essential access to the website and app
Magazine delivered every week
Investment ideas, tools and analysis

Have an account? Sign in